THE PLATELET QUESTION
Dr. Loong (Sydney) I would like to ask Dr. Gilcher about platelet availability. How many platelet units would he have available for emergency use in a population of three million? Dr. Gilcher (Oklahoma, U.S.A.) The population of the' State of Oklahoma is 3.1 million and we supply about half the State. Our geographic area is immense compared with the area of Sydney. We have three subcentres in addition to the primary centre, all of those stocking platelets. They keep approximately 10 units of platelets and 12 units of whole blood (6 group 0 and 6 group A) at each of the subcentres, which are 100 miles from the primary centre. I'm in the primary centre and we keep 200 units of platelets available. We have a five-day dating period on our platelets and if a patient requires more platelets than that, then appropriate action can be taken. We have a transportation system that can reach any point in our region within two hours, but it could take that long for the second batch of platelets to reach the patient.
Unknown Questioner
Dr. Lovric, I'm not sure if I heard you correctly, but concerning platelets we heard in your talk that ultrafresh blood is not a good source of platelets. You say a unit of platelets would have three times the value of a unit of fresh blood. Could you clarify that? Dr. Lovric (Sydney) These are the facts of the matter and I will explain how you can work that out. If you measure the recovery of platelets from three units of fresh blood and you measure the recovery of platelets from one unit of concentrate which has been prepared according to the usual standards, you will find out that you have roughly two or three units of ultrafresh blood achieving the same effect as one unit of concentrate. Dr. Dodds (Sydney) I would like to disagree. The data about platelet increments produced by transfusions isn't necessarily valid. If you transfuse platelets from whole blood that's been stored for a period of time you may get a good posttransfusion increment, because the platelets are ineffective and remain circulating, whereas if the increment is not great, it may mean in fact that they're better haemostatically and they're being very well utilised. Dr. Isbister (Sydney) I would like to support what Dr. Dodds says. What Dr. Lovric is saying is not the experience of most cliniCians. I would like to see the data to support his statements. As Dr. Dodds says, you do not take account of the important issue of the function of the transfused platelets concentrates which, when stored at room temperature, do not regain their normal function until some hours after transfusion. This fact is well documented in the literature. With the change to five-day storage of platelets, this fact may be of increasing importance when immediately functioning platelets are required. Post-transfusion survival is important in prophylactic platelet transfusions, but posttransfusion platelet increment, function and bleeding time are all important in the patient who requires the immediate haemostatic effect of platelets. That is the situation we are discussing in this symposium. There are similarities between what I am saying about platelets and the condition of stored red cells and their ability to immediately transport oxygen after transfusion. Most transfused cells are in a "make or break" crisis in the hours following transfusion. If they survive the initial transfusion their survival will be normal, assuming there is not increased loss or consumption due to the patient's clinical state. Dr. D. G. Runcie I wonder if Or. Lovric knows how great the problem of platelet availability can be. I work in a hospital of 400 beds which serves an area of about 200,000 patients. We went through the figures and found that, in two consecutive years, ten patients developed microvascular haemorrhage in association with massive blood transfusion in one year, and eight the next. Of those patients, half were given platelets. Of the ones that were given platelets, one died and eight survived. Of the nine who did not receive platelets, one survived and eight died. The one that died who was given platelets received them late in the illness. The reason why they weren't given platelets was because they weren't available in the time required. We now collect our own fresh blood on site and we find this is a straightforward and simple procedure. The blood is not collected by the person looking after the patient, but by someone else. You made the point about giving non-hepatitis B screened blood. If the donor selected is known to be screened previously and found to be clear and with no previous illnesses, we believe the risk is small. That's what we do; we find it satisfactory and straightforward. I'd make a plea for all of us here who work in outlying Anaesthesia und Imcflsh'c Care, Vo/. 12, No. 3, Augus(, 1984 areas that fresh whole blood "on the hoof" may be lifesaving.
Dr. Lovric
Platelets are still short in supply and there is no denying that. I don't want to minimise that problem and we are acutely aware of this at the Blood Transfusion Service. We are aware also that each teaching hospital in this city has a cell separator machine where they could provide blood for their own patients on cytotoxic therapy, but unfortunately they don't. Our blood bank prepares between 200 and 230 units of platelets daily for a population of about 3 million people. I'd like to know what Or. Gilcher does in Oklahoma.
Dr. Gilcher
We prepare 200 units per day for a population that we supply of about lA million.
FRESH FROZEN PLASMA, CRYOPRECIPITATE AND SUPERNATANT PLASMA
Dr. Horqn (Sydney) I'd like to direct a question to Or. Gilcher. It strikes me that you may not have haemophilia as a problem in your community. I say that because, if we request fresh frozen plasma in Sydney, the immediate response is always to give us cryosupernatant plasma, the cryoprecipitate being used in the treatment of haemophilia. I'd like to ask you how you see cryosupernate as an alternative to fresh frozen plasma in the treatment of massive haemorrhage.
Dr. Gilcher
We do have haemophilia. In the United States almost all of the haemophiliacs up until now have used Factor VIII concentrate instead of cryoprecipitate. Our cryoprecipitate has been a source of fibrinogen and opsonins. All subcentres keep 10 units of cryoprecipitate available. We don't have the problem of keeping cyroprecipitate available for haemophiliacs because very few have used cryoprecipitate. However, this has been changing recently with the evidence that AI OS is more common when factor VIII concentrates are used. We don't provide cryoprecipitatepoor plasma.
Dr. Isbister
As Or. Horan just said, supernatant plasma is commonly used in Sydney with the aim of assisting in the supply of Factor VIII and to avoid wastage of fresh frozen plasma. Most people would agree that the majority of patients who require fresh frozen plasma don't require the cryoprecipitate component (i.e. factor VIII, fibrinogen, von Willebrand factor and fibronectin). I'm referring to patients with liver disease, jaundiced patients with vitamin K deficiency or patients on oral anticoagulants. There is only a limited number of haemostatic disturbances which need components that are in cryoprecipitate, but the massive blood transfusion situation is one where you probably do need the full fresh frozen plasma because factor VIII is one of the deficiencies which may develop and sometimes fibrinogen can be depleted if you're dealing with DIC or fibrinolysis. It is a controversial area and some people would argue that cryoprecipitate-poor plasma is made available because it's the only buffer you can put in the system to stop all the fresh frozen plasma being wasted. My comment would be that if you've got a person who is bleeding and has identifiable haemostatic defects, there must be clinicians involved who understand those defects and can supervise the administration of the specific components. Now it's not always easy to have the people and the components you want when you want them and local arrangements are usually necessary to supply the required blood, such as fresh blood collected on site.
Dr. R. Wilson
Just to follow that up one step further, are you saying that cryosupernate plasma (cryoprecipitate-poor fresh frozen plasma) is in the system to "fob off" surgeons and anaesthetists and to make the whole system run a bit more efficiently or are you saying that it's a reasonable thing to have at this stage?
Dr. Isbister
It is quite a reasonable product to have as most patients who need plasma only require the components that are in cryoprecipitate-poor plasma. I would also make the point that the majority of patients who receive frozen plasma don't need plasma at all, so why waste full fresh frozen plasma? Why not just provide cryoprecipitate-poor plasma? We clearly need to educate the consumer. However, there are central blood banking policies and there are patient policies involved, and unfortunately they are not always compatible.
Dr. R. Wilson
If you are in a clinical situation of being forced to use "oldish" (> 2 weeks old) stored whole blood for a massive transfusion, a not ideal situation but happening to all of us reasonably frequently, you are using blood which has depleted levels of factor VIII and V and platelets amongst the other disadvantages that Dr. Isbister mentioned in his presentation. It would seem to me that under these circumstances using fresh frozen plasma has a realistic place.
Dr. Isbister
In general I'd agree, but such an approach would not negate the need to identify any specific defects. It has been well shown that when you're dealing with patients who have continued bleeding they don't stop until you identify and correct the specific haemostatic defect. If those facilities are not available, you may have to use "shotgun" therapy which is either going to be multiple component therapy (i.e. fresh frozen plasma, cryoprecipitate, and platelet concentrates) or fresh blood. The use of fresh blood I again emphasise, mainly because it is a quickly available source of normally functioning platelets. Most clinicians have experienced the problem of not being able to obtain platelets quickly. As has been mentioned there are difficult logistic problems in their supply in the acute haemorrhage setting and, to emphasise it again, one also wants immediately functioning platelets, which is not the case with platelets which have been stored at room temperature.
WHOLE BLOOD VERSUS PACKED RED CELLS

Unknown Questioner
In some places where you are unable to obtain whole blood, do you believe whole blood is still ever indicated? Dr. Isbister I think a lot depends on the age of blood being transfused. I agree essentially with Dr. Gilcher that an acutely bleeding patient should have whole blood available, and I'd prefer to have blood that's less than ten days old because of the better oxygen transport right from the outset. I think you're giving that patient volume and oxygen-carrying capacity. Initially you are not particularly concerned about the haemostatic disturbance. However, I know Anaesthesia and /l1fensive Care, Vol. 12, No. 3, August, 1984 • there are people, usually ones who are not directly involved in patient care, who say you can achieve the same by taking red cell concentrates and mixing with plasma and are recommending such an approach. Each blood bank, hopefully in consultation with the consumer, makes a decision as to what proportion of blood should be fractionated. Some say that 100070 of blood should be fractionated, others would advocate 50070. Approximately 75070 seems to be a reasonable compromise.
Dr. Gi/cher
Our fractionation is even higher. We fractionate about 85070 of our blood into components, so we only leave about 15070 whole blood in the system. That whole blood is then predominantly used for the trauma victim; that is, the exsanguinating patient. It doesn't represent very much of the blood in our system and if the situation does arise where it's not available, we do exactly what Dr. Isbister said, that is to resort to the combination of red cells plus fresh frozen plasma. Dr. Runciman (Adelaide) Do you have any age limit on your whole blood? We have got into trouble in this respect and may have done the patient additional harm.
Dr. Gilcher
Our whole blood is not collected in single bags. We collect everything in a double bag or triple bag. If it's in a double bag a unit of whole blood, after about 15-20 days of storage, is converted to a unit of red cells and the plasma is pooled. So the oldest whole blood our blood bank would issue is under three weeks old.
Dr. Runciman
We recently transfused about 12 units of 20-day-old whole blood into a patient in about 5 minutes and spent the next half-hour trying to bail the patient out of trouble, with serum potassiums of 9 and 10 mmolll. I would emphasise that if you're going to supply whole blood, there should be some more rigid limit on the age if it is to be infused rapidly.
Dr. Gilcher
I understand the point that you're making, but the same applies to aged red cell concentrates. Let me point out that if you look at the amount of potassium released in a unit of 20-day-old red cells versus the unit of 20-day-Anoeslhesia and lnfensive Care, Vol. 12, No. 3. August, /984 old whole blood, it's identical. If you were to take a unit of 20-day-old red cells and add fresh frozen plasma to it, you would have the same potassium level in that as you would in a unit of whole blood.
Dr. Isbister
We don't always know how blood has been stored and most of the published posttransfusion survival studies have been done under research conditions. If samples are taken from the actual blood units given to a patient we do get some surprises at times. I think most people would agree, there is no guarantee how a bottle of blood has been stored if it's a unit which has been crossmatched several times and travelled to and from operating theatres. It may have been left out at room temperature for considerable periods of time. I have clearly identified patients who have haemolysed whole units of blood without any clear serological reason. When I looked at the unit of blood it was haemolysed, and probably had not been stored properly. I believe that the older the blood, the greater the likelihood it may not have had ideal storage conditions throughout its life.
Dr. R. Wilson
Could we come back to the initial question of the provision of whole blood and what percentage of blood collected is being fractionated for component therapy? Could we have a brief response from the panel as to whether the provision of whole blood in centres, at least for massive transfusion, is essential, preferred, or not necessary, in 1983? In some centres in N .S. W., it is very difficult to obtain whole blood and in some places it is not. We heard the difference between central and peripheral policies on this matter. Would the panel like to briefly summarise their feelings?
Dr. Gi/cher
We don't feel that it's essential; however, we do feel it's desirable to have whole blood available for the massively bleeding patient. However, there is another way to skin a cat and one can do it with red cells and fresh frozen plasma.
Dr. Runciman
I think the management of massive trauma or the critically ill patient presents logistic problems and if you can mobilise the personnel in a large institution you should be capable of using packed cells in saline. I think it is just one component in the overall problem of managing exsanguination. If you are isolated I think there would be greater argument to have whole blood.
Dr. Isbister
I think that if you resuscitate people with packed cells and volume alone (crystalloid or colloid) you are going to run into depletion problems earlier. Whether you avoid these problems by giving stored whole blood is debatable. If you analyse the literature carefully and study patients closely it is not really clear why some patients get the haemostatic disturbance and others don't. It is not always a clear mathematical formula by which you can show the problem is dilutional. There are so many other factors contributing that I am wary of a protocol approach and I make the point that if the patient doesn't stop bleeding attempts should be made to identify any haemostatic defect.
Dr. O'Neill (Wollongong)
We fractionate 100070 and in the last three years all major accident victims in our hospitals have been treated with packed cells crystalloid and/or fresh frozen plasma which is freely available all the time, as are platelets. Whole blood has no great benefit apart from volume unless it is fresh whole blood. We say if you have got packed cells we can supply you with fresh frozen plasma immediately and platelets so it is the equivalent of fresh whole blood and nobody in Sydney can supply that to every major accident.
Dr. Isbister
You are being rather naive to refer to a mixture of stored red cell concentrates, fresh frozen plasma and platelet concentrates as the same as fresh blood. I think even the most committed fractionators would disagree with you. You will also have the problem of increased antigen exposure, where your patient receives blood from many more different donors. There is also the increased risk of posttransfusion infections. If you expose a person to 10 units of platelets, another set of donors' fresh frozen plasma and other donors' red cells, you will increase the risk of infection, not only hepatitis, but the mononucleosis-type syndromes such as CMV. Clinicians who say they do not occur are probably not looking carefully enough or are unaware of the clinical features.
Dr. O'Neill
The ideal situation would be if we could get the whole blood from donors to match everybody who needs a transfusion and less than 24 hours old, if you want to have full platelet function. It is not logistically possible and doesn't seem practicable to treat people with a minimal number of donors of fresh whole blood less than 24 hours old.
Dr. lsbister
We are not talking about initial transfusion. I am talking about patients who have received their initial resuscitation and who are still bleeding and developing the haemostatic defects of the massive blood transfusion syndrome. What I disapprove of is the Bandaid therapy that goes on for several hours or even days when patients are given multiple products when really a more sensible approach should be taken. I agree with Dr. Runciman's comments that logistic problems should not be stopping us doing what's best for the patient.
Dr. Lovric
I am from the Sydney Blood Bank. I'm the person who endeavours to provide you with all this "junk" from the sound ofthings. To come back to the issue that we discussed. The first one is Dr. O'Neill's and I think you would have the full support of the policy of our transfusion service. I think it is important to stress that if you provide the surgeon or the resuscitationist with blood that flows freely and to which you don't have to do other things they are going to use it.
I would also take issue with what Dr. Isbister has said about the storage history of units of blood. Dr. Isbister wouldn't be travelling on the right-hand side of the road here in Sydney because he felt that was the way to travel. We have rules in this game as to how to handle blood and if somebody is mishandling blood and keeping it outside a refrigerator that person should not be handling blood. It's no good saying that blood which is 35 days old is suspect because it's 35 days old. We believe that we share the same road when we issue the blood and we believe that medical education at all levels of our organisation is sufficient to tell people why we do that. It's no good saying that it is not done and blood is kept out of the AnaeSlhesia and Intensive Care, Vol. 12, No. 3, August, 1984 fridge. If you know if these situations do occur, it's your problem and you should rectify it.
Dr. lsbister
Or. Lovric, we live in a real world and I feel it rather naive to assume that all medical personnel have a sound knowledge of clinical blood transfusion and that all units of blood can be stored perfectly for 35 days.
FRESH BLOOD
Dr. Healy (Sydney)
Or. Gilcher made the comment that as soon as blood is cooled you lose some platelet viability. Or. Isbister supported the use of fresh blood. Could I ask if you use fresh blood should it be warm? Dr. Gilcher I am not sure if we will get two opinions here or not. To be truly fresh blood it must not have been cooled below room temperature. There have been studies done that show once platelets are kept at 4 QC no matter how fresh, at just four hours of age those platelets have decreased survival in a patient. Dr lsbister I would agree, and any apparent differences are due to a question of semantics. Some people call uncooled fresh blood "super-fresh" or "blood on the hoof" and blood less than 5 days old, "fresh" blood. I don't mind what people call it as long as they know what's in it and what works.
Dr. Stern (Sydney)
I think Dr. Lovric has outlined some of the reasons why some of us believe in fresh blood "on the hoof". In isolated areas you would have to concede that fresh blood is the most readily available, and in some cases the only source of platelets. I may be overreacting but we do really care for the donors. I think your comments are wrong and I would feel that in most places there are good facilities for the donor, and any problems they might have following donation can be attended to. In our hospital the collection of blood is usually done by experienced people.
Dr. Lovric
For your interest, 17 out of the 29 country blood banks use components in the State of New South Wales, so every large Base Hospital is making components along the same lines as the Sydney Blood Bank. As to the care of donors, I take your point. In some places the Al1ae.whesiu and intensive Care, Jla/. 12, No. 3, AI/gasl, 1984 donors are cared for, but I would point out that I am aware that in some places, when the pressure is on, it's the patient who is cared for and not the donor.
Dr. R. Wilson
The question of the care of the donor is a major one and in some hospitals, I would agree with Or. Lovric, the donor is relegated to being a second-class citizen and is lost in the rush to care for the patient with major haemorrhage. That has been my experience on a number of occasions. I think the second, more important issue is the question of who actually activates the collecting of the blood and then guarantees that it is used appropriately. I think it's an important decisionmaking or organisational structure that each hospital has to develop so there is a clearly defined procedure.
Dr. Runciman
We appear to be spending most of the time discussing the factor that's the least problem. We get an excellent transfusion service in general terms and it's not the limiting factor in acutely bleeding patients. The limiting factor is the early recognition of bleeding, the adequate arresting of bleeding and initial resuscitation. I think if you're looking at overall patient morbidity, the factors we've been discussing are probably in the 10,10 region.
Dr. R. Wilson
I think it's fair comment to say that most of the patients with massive transfusion probably have spent longer having their first intravenous line put in than it takes to get the first unit of blood from the blood bank to the bedside and I think Or. Runciman's point is well made.
INDICATIONS FOR COAGULATION STUDIES AND THEIR INTERPRETATION
Dr. R. Wilson
At what stage in the resuscitation of massive transfusion is it worthwhile measuring the coagulation parameters? What do they mean and at what stage should expert haematological assistance be sought?
Dr. lsbister
The answer to this will vary from patient to patient. If there is clear evidence of general haemostatic failure, such as bleeding from multiple sites, purpura or poor clot formation, a platelet count and coagulation screen (PT, PTTK and TT) should be done at the outset and appropriate action taken. If there is known pre-existing disease which may alter the haemostatic system (e.g. liver or renal), this should be appropriately assessed. When the bleeding is solely surgical or traumatic from the outset one should not be preoccupied with the possibility of haemostatic failure. However, after a patient has been transfused five to ten units of blood it is advisable to check the haemostatic system, mainly to detect any trends which may be developing so early action can be taken.
When there has been established shock, continuing blood loss or signs of developing haemostatic failure it is important that the patient be correctly investigated and specific defects identified. As I pointed out in my talk, patients who continue to bleed when surgical haemostasis has been achieved and have a defect in haemostasis will not stop bleeding until the specific defect is corrected and the involvement of a haematologist is desirable. However, I would agree that haematologists in general have a reputation for not showing a great deal of interest in these problems.
HAZARDS OF HOMOLOGOUS BLOOD TRANSFUSION
Dr. R. Wilson
One question I'd like to put to the panel which I don't think has been sufficiently discussed today is the question of the morbidity and mortality of homologous blood transfusion in the community in which we work. We certainly have figures in the literature, but I'm not sure how many people in the audience are aware of the morbidity and mortality of blood transfusion.
Dr. Lovric
I don't have any personal figures on this. The only figure I can quote is the one presented by Conrad recently where he said that the complications of blood transfusion amount to the same risk as for an abdominal exploration which I think is 1070. As to the mortality, the only figures again that I can put my hands on are those recently published in the United States reviewing seven or eight years' experience and quote 160 deaths over that period of time, reported to that particular unit. From memory 60-70070 of these were due to hepatitis. If you exclude that particular group the remainder were due to incompatibility, of which all but five or six were due to clerical errors and six were due to transfusion problems related to antibodies which were not clinically detected or perhaps missed.
Dr. Gilcher
I might comment that I think the 1070 figure is far too low. If one includes as complications of transfusion all the things that can happen to a patient and I'm specifically talking about hepatitis, I think the complications of homologous transfusions probably truly approach somewhere around 8-10070. That includes everything from febrile transfusion reactions to all of the diseases that can be transmitted by blood.
Dr. Davies
I think it's very difficult to estimate the incidence of reactions. Certainly in the U.S.A. figures are often quoted and they're very similar to West Germany which is the only other area I know where the incidence of posttransfusion hepatitis is around 7.5070. In our hospital non-haemolytic reactions in 1978, I think, totalled 0.7070 which, I think, is 10 times the incidence of reaction associated with colloids. These non-haemolytic reactions we often underestimate.
Dr. Dodds
A survey was done in Sydney following cardiac surgery at St. Vincent's and Prince Alfred a year or so back and I thought the figure was 6070 of patients who developed a significant rise in their liver enzymes following cardiac surgery.
THE INTERSTITIAL DEHYDRATION CONTROVERSY
Dr. R. Wilson I would like to ask Dr. Gilcher about the concept of interstitial dehydration following haemorrhage. If your patient bleeds out and you replace it with whole blood, why would the patient develop interstitial dehydration?
Dr. Gilcher
The time course is the critical factor and I perhaps didn't emphasise that enough. I'm talking about the time in which the patient is subjected to hypovolaemia. If you get a significant prolonged period of hypovolaemic shock, you do get interstitial dehydration and the patient does require crystalloid. On the other hand, if volume replacement is much quicker, then it is less of an issue, but there is no question that it is an issue from the military side and has become an important issue to us in the United States, and as you know the Israelis made very good use of that in their seven-day war. That's how they resuscitated 90070 of their battle casualties.
Dr. M. Fisher (Sydney)
I am a little concerned. I am concerned that those who don't know and haven't thought about this heresy of interstitial dehydration may go away with the wrong idea. Firstly, you must realise this is something believed in by small groups in America and it's never really been accepted in Australia, England, Scandinavia or Europe. It's particularly an American phenomenon. De Warden er showed in animals in the 1940s that if you maintain blood volume, and gave someone enough fluid to get rid of their solute load, it didn't matter if your ECF volume approached zero. ECF dehydration doesn't hurt, in fact it's good for you. Homer Smith showed that humans don't respond to having their ECF expanded, but they respond very well to having it reduced. That was in the 1950s. The British said later that in volunteers a 2-litre ECF expansion causes deterioration in lung function: dehydrating volunteers made an improvement in lung function.
It was in the Korean War that we first learnt about interstitial dehydration, and this was American data, when Mills wrote that ECF expansion and high urine output caused an inordinate amount of pulmonary oedema in fit young patients which carried 50070 mortality. The Americans didn't learn the lesson. The best Vietnam studies found that patients 2-litre dehydrated when they came from the battlefield, who had their volume restored with Ringer's lactate solution and were maintained at a high urine output, had an overexpanded ECF and they concluded that this was not beneficial, and if the patients had not been fit young people this would almost certainly be detrimental. The same has been shown in a number of other studies. Certainly the therapeutic benefits of shrinking ECF partic,ularly in fat embolism have been shown by both Americans and Australians: basically, "dry is beautiful" in sick patients, and interstitial dehydration doesn't hurt you -it's good for you! Anaesthesia {lnd Infellsive Care, Vol. 12, No. 3, AlIgllsl, 1984 Dr Gilcher I'm afraid we can't totally agree with you. We're not advocating overexpansion of the interstitial compartment, we're advocating reexpansion of the interstitial compartment, because there are a number of studies that show that transport of oxgyen and glucose is decreased due to alterations in the chondroitin sulphate material which is concentrated.
Dr. lsbister
Malcolm, when you say "dry is beautiful", what do you do if you're having trouble maintaining someone's circulating volume, perhaps with a capillary leak, or you want to dry their lung out and they're getting hypovolaemic? Dr. Fisher I think we've satisfied ourselves in a lot of circumstances, although we only have good data from anaphylactic patients and some data on invenomated patients, that by using positive end expiratory pressure (PEEP) you can restore these patients' blood volumes with colloid solutions but not crystalloid. There are some you can fix with crystalloid, but certainly the bad ones need colloid and PEEP may fix the situation, but you have to maintain blood volume. The other thing we suspect, and again we have no data to support it, is that if patients are kept dry and then become septic their renal function may be jeopardised more than a patient who is overhydrated; but similarly, the overhydrated patient who gets a septic insult gets ARDS. ARDS is a rare disease in Australia, unlike America where they tend to overexpand the ECF with crystalloid.
Dr. Runciman
Are we not deluding ourselves that we have some insight into the mechanisms that operate because some of the facts don't fit any of these hypotheses at all? What do the two speakers think of the work on hypertonic saline which has shown that in haemorrhagic shock, both in experimental animals and in some reports in man, you don't have to worry about volume at all or expanding the extracellular fluid volume: you simply give the right number of millimoles of 7.5 N saline (2,400 molality) and blood pressure comes up, the pulse rate slows down and the patients recover? Dr. Fisher I think the comments that were made when Or. Jo Civetta first presented this data in Australia are still relevant. We don't have any idea how hypertonic saline works. It certainly challenges all the concepts we have, and of people who are using this therapy one should ask them, "Does your mother know you're doing that to humans?" AUTOLOGOUS BLOOD TRANSFUSION Dr. Loong I would like to ask Dr. Davies his approach to patients with polycythaemia in the context of preoperative autotransfusion. Secondly, in the haemodilution technique, how do you agitate the blood as you are collecting it, and thirdly, when you're reinfusing that blood, do you put it through a 170-micron filter or through a microaggregate filter? Surely you're losing platelets from scavenged blood if you're putting it through a filter.
Dr. Davies
First of all, I omitted to mention that polycythaemia is one of the very good indications for haemodilution, but the haematologists have usually done it for you. The only trouble is they may unfortunately have thrown the blood out. If you do come across a polycythaemic patient for an emergency operation, then you've got a good haemoglobin to start with and you can certainly proceed with haemodilution.
In answer to the question about agitation, we pick up the pack and move it around and tip it upside down and see whether it's dripping and all those sorts of things. You've got to do that or you certainly will get clots. Collecting it from the arterial line gives rapid flow and there's not a great problem. You have to be much more careful with agitation if you take the blood from a vein.
We don't filter the autologous blood collected, but give it through a platelet giving set which I think is the correct thing to do. Scavenged blood has to be filtered. We don't actually worry about the loss of platelets as I don't think we're getting any platelets from it in any case. If you're using scavenging, you've got to be aware that you'll have to use component therapy.
Dr. Runciman
In relation to education, I think the ultimate answer is for patients coming in for elective procedures or when they book in for surgery, by a mechanism that is independent of the surgeons, to be given a document outlining the advantages of autologous blood transfusion. I think one probably has to bite the bullet of this political hurdle at some stage. Or. Isbister addresses many of these problems in his paper.
Unknown Questioner
My question concerns the use of autotransfusion and blood from autotransfusion. If you look at haemodialysis and you measure the P a o 2 during haemodialysis and immediately after haemodialysis, you find that sometimes the P a o 2 drops and this is thought to be related to alternative pathway complement activation with leucocyte aggregation and filtering out in the lungs. At least that's one theory. I wonder if you've looked at gas exchange with regard to autotransfusion and if there are any changes that we should know about.
Dr. Gilcher
We've looked at P a o 2 in these patients and have not seen any evidence of this "angry neutrophil syndrome" which causes sequestration in the lungs and sets off a whole host of problems. There is no evidence for this when using the washed red cell preparation. I cannot speak with regard to the non-washed red cell preparations.
Dr. Davies
Using the non-washed red cells, most of the data is related to the use of the Bentley equipment which is different from what I'm trying to study at the present moment. There have been no oxygenation problems intraoperatively or early postoperatively with that system and in our preliminary studies, this hasn't been a problem either. It's something that you really need to keep a very close eye on because there are a lot of other reasons why arterial oxygen tension may drop and it's essential for safety that this aspect is not altered in any way.
SEROLOGICAL ASPECTS OF MASSIVE BLOOD TRANSFUSION
Unknown Questioner
Or. Gilcher, a new quick (approximately 12 minutes) crossmatch technique has been developed using the saline plus polybreen which will pick up IgG antibodies which cause extravascular haemolysis. Could you comment on this method and its reliability? Dr. Gilcher I would like to stress that I have seen more patients injured because of a non understanding of the difference between intravascular versus extravascular haemolysis. The moment incompatible blood is mentioned the clinician immediately has vision of a fatal haemolytic transfusion reaction. It is only the immediate acute intravascular haemolytic reactions which are of importance in the acute haemorrhage setting. The more delayed extravascular reaction which occurs several hours later, although it may be clinically significant, is not life-threatening and the failure to give the blood may be of much greater significance for the prognosis of the patient. What is needed is oxygen-carrying capability and volume support at this critical time for the patient. On occasions we will cross the Rh barrier even in spite of the fact that we find an IgG antibody because the Rh antibodies do not bind complement and will not elicit a life-threatening intravascular haemolytic transfusion reaction. We would not be concerned about the immediate effects of extravascular haemolysis. Later in the patient's course the bilirubin may rise, the haematocrit fall, but the patient has been supported through the acute phase. So I really want to stress that despite new serological techniques, the critical phase of any crossmatch remains the saline reaction, that detects the IgM complement binding antibodies (usually ABO blood group system related) that produce potentially life-threatening intravascular haemolysis.
Dr. lsbister
Could I just support those comments and add some more? When you review the literature ;tf/a(!SI/lesiu and Intcnsive Care, Vo!. 12, No. 3, Augusf, /984 relating to people who have supposedly died as a result of an incompatible blood transfusion, that is, incompatible on the Coomb's phase of the crossmatch, it is difficult to be convinced in many cases that it was the transfusion that killed the patient. In many cases there were numerous other factors which could be responsible or contributory. When a person dies in relation to a blood transfusion, as a result of what appears to be incompatible blood, the blood is always found guilty by association. If you closely examine why a lot of these patients died, one realises there are a lot of other things that are going on and that more have died because of the blood or volume that they didn't get rather than the blood they did get.
I would also make the point that in massive blood transfusion we don't always know what we're crossmatching the donor blood against because the person who has had his volume changed once or twice has other people's blood circulating, not his own.
I was rather worried to find out some time ago that there are some hospitals in N .S. W. that throw out the initial blood sample that is collected by paramedics who have resuscitated the patient on site. This is done on the grounds that the hospital can't confirm the identity of the patient and sample. I can understand concern about identity, but as long as the person's group is checked and you're giving group-specific blood, you're on safe ground transfusing that patient, but if you 'ye thrown out a vital piece of information, which in retrospect may tell you whether that patient has or hasn't got antibodies, I believe a serious error could be made. I would also say that the paramedic system for identifying patients is much better than the system in most hospitals.
